Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Change in Inventory (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Change in Inventory for 10 consecutive years, with -$1.9 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Change in Inventory fell 7.47% year-over-year to -$1.9 million, compared with a TTM value of -$2.4 million through Jun 2025, up 59.05%, and an annual FY2023 reading of -$4.1 million, down 160.4% over the prior year.
  • Change in Inventory was -$1.9 million for Q2 2025 at SRx Health Solutions, down from $643000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $3.3 million in Q1 2022 and bottomed at -$2.1 million in Q1 2023.
  • Average Change in Inventory over 5 years is -$129777.8, with a median of -$171500.0 recorded in 2021.
  • The sharpest move saw Change in Inventory skyrocketed 52075.0% in 2021, then crashed 2407.14% in 2023.
  • Year by year, Change in Inventory stood at $2.1 million in 2021, then crashed by 102.68% to -$56000.0 in 2022, then plummeted by 2407.14% to -$1.4 million in 2023, then increased by 16.45% to -$1.2 million in 2024, then plummeted by 64.28% to -$1.9 million in 2025.
  • Business Quant data shows Change in Inventory for SRXH at -$1.9 million in Q2 2025, $643000.0 in Q1 2025, and -$1.2 million in Q4 2024.